Message from the President

Y.S. Photo
Yukitoshi Satoh, MD, PhD
President, Japanese Society of Clinical Cytology
(Department of Thoracic Surgery, Kitasato University Hospital)
I was appointed the President of the Japanese Society of Clinical Cytology (JSCC), succeeding our esteemed former president, Prof. Daisuke Aoki, and it is my great honor to address you.

JSCC was established in 1961 and founded as a Gynecologic Cytology Committee. Over the past 60 years, JSCC has grown and developed, aiding many people. I became a member of the JSCC in 1986 with a start in cytology, and I have been active as a cytopathologist since 1991. During these 30 years or more of membership, I have especially been taken care of here by many of my seniors, colleagues, and juniors.
The JSCC fulfilled its long-held ambition of becoming a public interest incorporated association in 2013, a change that has made JSCC’s direction clearer. I think it is a starting point, and we will continue to grow into an organization. It is my hope that the JSCC will be worthy of the designation in both name and substance through our contributions to the health and wellbeing of the public.
As the JSCC President, I have been tasked with building a solid foundation upon which the future of our society may be built. I begin my term as the president with the following three goals:
1. Supporting the medical setting
Clinical cytology, which is composed of cytotechnologists and cytopathologists, is now contributing to cancer screening and diagnosis of illnesses. Hence, we will work hard to provide the clinical cytological medical care most suitable for individual patients.
2. Supporting research activities
The information and activities bearing the JSCC name require stringency and must strive always for excellence. We therefore provide support for research activities and for the scholarly and scientific study of clinical cytology.
3. Transmitting information on cytology
Through our research and collaboration, we produce information about routine cytologic diagnosis, research results, and an international cooperation in cytology fields. Because the JSCC journal is an important tool for information transmission, we will review the contents to ensure that we publish only the highest quality research.
At present, the medical field in Japan is changing rapidly. Therefore, it is difficult to predict the future of clinical cytology. However, the JSCC should contribute to maintaining the public’s health through our medical work, research, and how we share that research. I sincerely appreciate your attention and your support to the JSCC as we pursue these goals.